Related Experiment Video
Updated: Jan 18, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
A Synthetic Sponge System Against miRNAs of the miR-17/92 Cluster Targets Transcriptional MYC Dosage Compensation in
Diana M Bravo-Estupiñan1,2,3,4,5, Carsten Geiß6, Jorge L Arias-Arias2
1Programa de Doctorado en Ciencias, Sistema de Estudios de Posgrado (SEP), Universidad de Costa Rica, San José 20601, Costa Rica.
Background:
Genomic instability, a hallmark of cancer, leads to copy number variations disrupting gene dosage balance and contributing to tumor progression. One of the most affected oncogenes is MYC, whose overexpression is tightly regulated to avoid cytotoxicity. In aneuploid cancer cells, gene dosage compensation mechanisms involving microRNAs (miRNAs) from the miR-17/92 cluster contribute in regulating MYC expression. Targeting this miRNA-mediated compensation system represents a promising therapeutic strategy leading to an uncontrolled and lethal MYC overexpression.
Results:
Synthetic miRNA sponges targeting miR-17, miR-19a, and miR-20a, key regulators of MYC dosage compensation, were designed and validated. Breast cancer cells (MCF7) with stable exogenous MYC overexpression were used to assess the impact of sponge constructs on MYC regulation. Quantitative RT-PCR revealed a significant reduction in miRNA expression and a corresponding increase in endogenous MYC levels upon sponge treatment. Functional assays in multiple colorectal cancer cell lines with varying MYC copy numbers demonstrated a time-dependent increase in cell death following sponge transfection. Cytotoxic effects increased with MYC copy number, confirming a correlation between gene dosage sensitivity and therapeutic response.
Conclusions:
Our findings demonstrate that miRNA sponges targeting the miR-17/92 cluster can effectively disrupt MYC dosage compensation, leading to selective cytotoxicity in MYC-amplified cancer cells.
Insights
Targeting microRNAs (miRNAs) with synthetic sponges disrupts MYC gene dosage compensation in cancer. This approach selectively induces cell death in MYC-amplified cancer cells, offering a promising therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Genomic instability drives cancer progression via copy number variations and disrupted gene dosage.
- The MYC oncogene is frequently affected by copy number variations, with overexpression tightly regulated to prevent cytotoxicity.
- MicroRNAs (miRNAs) from the miR-17/92 cluster mediate gene dosage compensation for MYC in aneuploid cancer cells.
Purpose of the Study:
- To investigate the therapeutic potential of targeting miRNA-mediated MYC dosage compensation.
- To design and validate synthetic miRNA sponges targeting key miRNAs in the miR-17/92 cluster.
- To assess the impact of disrupting MYC dosage compensation on cancer cell viability.
Main Methods:
- Design and validation of synthetic miRNA sponges targeting miR-17, miR-19a, and miR-20a.
- Utilizing breast cancer MCF7 cells with stable MYC overexpression to evaluate sponge constructs.
- Quantitative RT-PCR to measure miRNA and MYC expression levels.
- Functional assays in colorectal cancer cell lines to assess cell death induction.
Main Results:
- Synthetic miRNA sponges significantly reduced miR-17/92 cluster miRNA expression.
- Sponge treatment led to a corresponding increase in endogenous MYC levels.
- Transfection with miRNA sponges induced a time-dependent increase in cancer cell death.
- Cytotoxicity correlated positively with MYC copy number, indicating gene dosage sensitivity.
Conclusions:
- Synthetic miRNA sponges effectively disrupt MYC dosage compensation by targeting the miR-17/92 cluster.
- This disruption leads to selective cytotoxicity in cancer cells with MYC amplification.
- Targeting miRNA-mediated compensation represents a viable therapeutic strategy for MYC-amplified cancers.
Related Concept Videos
MicroRNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

